Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Zeina A Yanbeiy, Karen E HansenRheumatology Division, Department of Medicine, University of Wisconsin School of Medicine & Public Health, Madison, WI, USAObjective: Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis. In May 2018, denosumab was approved f...
Сохранить в:
Главные авторы: | , |
---|---|
Формат: | |
Опубликовано: |
Dove Medical Press,
2019-08-01T00:00:00Z.
|
Предметы: | |
Online-ссылка: | Connect to this object online. |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
Шифр: |
A1234.567 |
---|---|
Копировать 1 | Доступно |